Found: 24
Select item for more details and to access through your institution.
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 1, doi. 10.1007/s00280-014-2566-x
- By:
- Publication type:
- Article
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 17, doi. 10.1007/s00280-014-2609-3
- By:
- Publication type:
- Article
Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 27, doi. 10.1007/s00280-014-2614-6
- By:
- Publication type:
- Article
A pharmacokinetic and pharmacodynamic investigation of Modufolin compared to Isovorin after single dose intravenous administration to patients with colon cancer: a randomized study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 37, doi. 10.1007/s00280-014-2611-9
- By:
- Publication type:
- Article
A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 49, doi. 10.1007/s00280-014-2616-4
- By:
- Publication type:
- Article
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 59, doi. 10.1007/s00280-014-2613-7
- By:
- Publication type:
- Article
Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 67, doi. 10.1007/s00280-014-2618-2
- By:
- Publication type:
- Article
Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 77, doi. 10.1007/s00280-014-2619-1
- By:
- Publication type:
- Article
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 87, doi. 10.1007/s00280-014-2612-8
- By:
- Publication type:
- Article
Population pharmacokinetics of HM781-36 (poziotinib), pan-human EGF receptor (HER) inhibitor, and its two metabolites in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 97, doi. 10.1007/s00280-014-2621-7
- By:
- Publication type:
- Article
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 111, doi. 10.1007/s00280-014-2617-3
- By:
- Publication type:
- Article
Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 123, doi. 10.1007/s00280-014-2624-4
- By:
- Publication type:
- Article
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 131, doi. 10.1007/s00280-014-2627-1
- By:
- Publication type:
- Article
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 143, doi. 10.1007/s00280-014-2623-5
- By:
- Publication type:
- Article
Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 153, doi. 10.1007/s00280-014-2628-0
- By:
- Publication type:
- Article
Biological evaluation of a novel sorafenib analogue, t-CUPM.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 161, doi. 10.1007/s00280-014-2626-2
- By:
- Publication type:
- Article
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 173, doi. 10.1007/s00280-014-2630-6
- By:
- Publication type:
- Article
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 183, doi. 10.1007/s00280-014-2615-5
- By:
- Publication type:
- Article
Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 191, doi. 10.1007/s00280-014-2636-0
- By:
- Publication type:
- Article
EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 197, doi. 10.1007/s00280-014-2631-5
- By:
- Publication type:
- Article
Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 207, doi. 10.1007/s00280-014-2632-4
- By:
- Publication type:
- Article
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 215, doi. 10.1007/s00280-014-2645-z
- By:
- Publication type:
- Article